Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in hospitalized patients with ARDS
NCT06701656Phase 2Recruiting
- Sponsor
- PPD
- Start
- Oct 2025
- Primary completion
- Jul 2028
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in acute respiratory distress syndrome (ARDS), sponsored by PPD. Started Oct 2025; status: recruiting.
02
Drugs
bevacizumab
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT06701656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06701656.